BQ Prime's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BQ Prime's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
India pharma market exhibited a growth of 16.6% YoY in June 2022 versus a 3.3% YoY decline in May 2022 and a growth of 14.3% in June 2021.
Gynecology/dermatology/pain/gastrointestinal were the major drivers of IPM growth, up 33.2%/23.9%/23.1%/21.4% YoY.
Growth was dragged by a 6.1% YoY decline in vaccines.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.